Is Mukka Proteins overvalued or undervalued?

As of 14 November 2025, Mukka Proteins has moved from an attractive to a very attractive valuation grade. The company is currently considered undervalued, with a price-to-earnings (PE) ratio of 16.74, a price-to-book value of 1.78, and an EV to EBITDA ratio of 12.74. In comparison, peer Avanti Feeds has a PE ratio of 16.54 and an EV to EBITDA of 10.04, while Apex Frozen Foods, which is rated fair, has a significantly higher PE ratio of 43.53 and an EV to EBITDA of 24.92.
Despite Mukka Proteins' recent stock performance lagging behind the Sensex, with a year-to-date return of -35.76% compared to the Sensex's 8.22%, the company's strong ratios suggest it is undervalued relative to its peers. The PEG ratio of 0.00 indicates potential for growth, reinforcing the attractiveness of the current valuation.